Contrasting Trulieve Cannabis (NYSE:TRLV) and Tilray Brands (NASDAQ:TLRY)

Tilray Brands (NASDAQ:TLRY) and Trulieve Cannabis (NYSE:TRLV) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk.

Analyst Recommendations

This is a summary of recent ratings for Tilray Brands and Trulieve Cannabis, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	2	2	3	1	2.38
Trulieve Cannabis	1	1	1	0	2.00

Tilray Brands currently has a consensus target price of $6.38, indicating a potential upside of 83.98%. Trulieve Cannabis has a consensus target price of $15.00, indicating a potential upside of 40.78%. Given Tilray Brands’ stronger consensus rating and higher possible upside, research analysts clearly believe Tilray Brands is more favorable than Trulieve Cannabis.

Profitability

This table compares Tilray Brands and Trulieve Cannabis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-13.11%	-7.76%	-5.59%
Trulieve Cannabis	-41.55%	-4.24%	-1.72%

Institutional & Insider Ownership

9.4% of Tilray Brands shares are held by institutional investors. 1.6% of Tilray Brands shares are held by company insiders. Comparatively, 3.8% of Trulieve Cannabis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Tilray Brands and Trulieve Cannabis”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$210.48 million	2.24	-$121.40 million	($1.08)	-3.21
Trulieve Cannabis	$1.14 billion	1.80	-$116.38 million	$0.11	96.86

Trulieve Cannabis has higher revenue and earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Trulieve Cannabis, indicating that it is currently the more affordable of the two stocks.

About Tilray Brands

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

About Trulieve Cannabis

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.